How to treat aorto-iliac occlusions?

Massoni, Claudio Bianchini; Ucci, Alessandro; Perini, Paolo; Nabulsi, Bilal; Freyrie, Antonio

doi:10.1016/b978-0-12-822113-6.00004-8

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Intervention should only be used for patients with limb-threatening claudication or claudication that restricts their lifestyle since patients with asymptomatic PAD are unlikely to benefit from endovascular or surgical therapies and may have difficulties connected to treatment. In addition, impotence is a common adverse effect among AIOD patients (2) .…”

Section: Introductionmentioning

confidence: 99%

Different Methods of Endovascular Techniques in Management of Aorto-Iliac Occlusive Disease

Kerdawi¹,

Serageldin²,

Galal³

2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: AIOD (Aorto-Iliac Occlusive Disease) may affect any of the arteries from the distal aorta to the common femoral arteries. CERAB (Covered Endovascular Reconstruction of Aortic Bifurcation) is a minimally invasive method used to treat significant and/or recurring aortoiliac occlusive disease. Bare-Metal stents are both effective and safe for treating AIOD. Bare-Metal stents had a statistically substantial greater risk of primary patency in both the general cohort and more complicated TASC C/D lesions.

show abstract

Section: Introductionmentioning

confidence: 99%